Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi-Lepri

Showing results (91-100 of 244) with videos related to

Pageof 25
Sort By:
Antiviral Therapy|June 25, 2008
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological responseKoen Deforche, Alessandro Cozzi-Lepri, Kristof Theys, et al.
AIDS (London, England)|August 30, 2008
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophyBarbara Zanone Poma, Agostino Riva, Milena Nasi, et al.
Journal of Medical Virology|October 26, 2006
Significant link between sCD30 changes and HIV viremia in patients treated with HAARTPriscilla Biswas, Alessandro Cozzi-Lepri, Fanny Delfanti, et al.
BMC Infectious Diseases|June 12, 2021
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIVEsther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
HIV Medicine|September 30, 2023
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) studyAlessandro Cozzi-Lepri, David Dunn, Anna Tostevin, et al.
The Journal of Antimicrobial Chemotherapy|February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 countsSilvia Nozza, Filippo Canducci, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2009
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosisAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of the International AIDS Society|November 15, 2014
Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study CohortAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohortFabio Vescini, Alessandro Cozzi-Lepri, Marco Borderi, et al.
Pageof 25

Showing results (91-100 of 244) with videos related to

Sort By:
Pageof 25
Antiviral Therapy|June 25, 2008
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological responseKoen Deforche, Alessandro Cozzi-Lepri, Kristof Theys, et al.
AIDS (London, England)|August 30, 2008
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophyBarbara Zanone Poma, Agostino Riva, Milena Nasi, et al.
Journal of Medical Virology|October 26, 2006
Significant link between sCD30 changes and HIV viremia in patients treated with HAARTPriscilla Biswas, Alessandro Cozzi-Lepri, Fanny Delfanti, et al.
BMC Infectious Diseases|June 12, 2021
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIVEsther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
HIV Medicine|September 30, 2023
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) studyAlessandro Cozzi-Lepri, David Dunn, Anna Tostevin, et al.
The Journal of Antimicrobial Chemotherapy|February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 countsSilvia Nozza, Filippo Canducci, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2009
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosisAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of the International AIDS Society|November 15, 2014
Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study CohortAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohortFabio Vescini, Alessandro Cozzi-Lepri, Marco Borderi, et al.
Pageof 25